合成路线1
该中间体在本合成路线中的序号:
(I) The esterification of bromoacetic acid (I) with benzyl alcohol (II) gives the corresponding ester (III), which by reaction with triphenylphosphine (IV) in hot toluene yields the phosphonium bromide (V). The reaction of (V) with NaOH in water-dichloromethane affords benzyl(triphenylphosphoranylidene) acetate (VI), which is submitted to a Wittig condensation with 5-(hydroxymethyl)-2-pyrrolidone (VII) in the presence of Dess-Martin periodinane (DMPI) giving benzyl 3-(5-oxo-2-pyrrolidinyl)-2(E) propenoate (VIII). The acylation of (VIII) with 4-methoxybenzoyl chloride (IX) by means of triethylamine in hot toluene yields the corresponding amide (X), which is finally hydrogenated and deprotected with H2 over Pd/C in THF.
【1】
Huang, C.C.; Synthesis of carbon-14 labeled 1-(4-methoxybenzoyl. J Label Compd Radiopharm 1987, 24, 6, 675.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(II) |
18710 |
Benzyl alcohol; Phenylmethanol
|
100-51-6 |
C7H8O |
详情 | 详情
|
(III) |
12869 |
benzyl 2-bromoacetate
|
5437-45-6 |
C9H9BrO2 |
详情 | 详情
|
(IV) |
12437 |
Triphenylphosphine; Triphenyl phosphine
|
603-35-0 |
C18H15P |
详情 | 详情
|
(V) |
22667 |
[2-(benzyloxy)-2-oxoethyl](triphenyl)phosphonium bromide
|
|
C27H24BrO2P |
详情 |
详情
|
(VI) |
22668 |
benzyl 2-(triphenylphosphoranylidene)acetate
|
|
C27H23O2P |
详情 |
详情
|
(VII) |
10079 |
5-(Hydroxymethyl)-2-pyrrolidinone
|
62400-75-3 |
C5H9NO2 |
详情 | 详情
|
(VIII) |
22670 |
benzyl (E)-3-(5-oxo-2-pyrrolidinyl)-2-propenoate
|
|
C14H15NO3 |
详情 |
详情
|
(IX) |
22671 |
4-Methoxybenzoyl chloride; p-Methoxybenzoyl chloride; 4-Anisoyl chloride
|
100-07-2 |
C8H7ClO2 |
详情 | 详情
|
(X) |
22672 |
benzyl (E)-3-[1-(4-methoxybenzoyl)-5-oxo-2-pyrrolidinyl]-2-propenoate
|
|
C22H21NO5 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(I) The title compound has also been obtained by solid phase synthesis. Bromoacetic acid (I) is coupled to hydroxymethyl polystyrene resin by means of DIC/DMAP to produce the bromoacetyl resin (II). Bromide displacement with tert-butyl carbazate (III) leads to the N-Boc hydrazino ester (IV), which is further deprotected to (V) employing trifluoroacetic acid. The hydrazinoacetic acid-bound resin (V) is then condensed with 5-(p-nitrophenyl)furfural (VI) to furnish hydrazone (VII). Acylation of resin (VII) with p-nitrophenyl chloroformate (VIII) produces the p-nitrophenyl carbamate (IX), which upon treatment with ammonia gives rise to the semicarbazone (X). Finally, concomitant intramolecular ring closure and resin cleavage of (X) produces the target aminohydantoin derivative (XI) (4, 5).
【1】
Wilson, L.J.; Li, M.; Portlock, D.E.; Solid phase synthesis of 1-aminohydantoin libraries. Tetrahedron Lett 1998, 39, 29, 5135.
|
【2】
Portlock, D.E.; Li, M.; Wilson, L.J. (The Procter & Gamble Co.); Solid phase synthesis of 1-aminohydantoins. WO 9942450 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(II) |
12309 |
methyl 2-bromoacetate; methyl bromoacetate
|
96-32-2 |
C3H5BrO2 |
详情 | 详情
|
(III) |
12091 |
1-Methylhydrazine; Monomethyl hydrazine
|
60-34-4 |
CH6N2 |
详情 | 详情
|
(IV) |
63589 |
2-[2-(tert-butoxycarbonyl)hydrazino]acetic acid
|
|
C7H14N2O4 |
详情 |
详情
|
(V) |
63590 |
2-hydrazinoacetic acid
|
|
C2H6N2O2 |
详情 |
详情
|
(VI) |
63583 |
5-(4-nitrophenyl)-2-furaldehyde
|
|
C11H7NO4 |
详情 |
详情
|
(VII) |
63591 |
2-(2-{(E)-[5-(4-nitrophenyl)-2-furyl]methylidene}hydrazino)acetic acid
|
|
C13H11N3O5 |
详情 |
详情
|
(VIII) |
16605 |
4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene
|
7693-46-1 |
C7H4ClNO4 |
详情 | 详情
|
(IX) |
63592 |
2-(1-[(4-nitrophenoxy)carbonyl]-2-{(E)-[5-(4-nitrophenyl)-2-furyl]methylidene}hydrazino)acetic acid
|
|
C20H14N4O9 |
详情 |
详情
|
(X) |
63593 |
2-(1-(aminocarbonyl)-2-{(E)-[5-(4-nitrophenyl)-2-furyl]methylidene}hydrazino)acetic acid
|
|
C14H12N4O6 |
详情 |
详情
|
(XI) |
63586 |
1-({(E)-[5-(4-nitrophenyl)-2-furyl]methylidene}amino)-2,4-imidazolidinedione
|
|
C14H10N4O5 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(I) A new synthesis of [14C]-labeled E-1040 with the label in the quinuclidine ring has been reported:
The reduction of [14C]-labeled bromoacetic acid (I) with borane-dimethyl sulfide complex in ethyl ether gives 2-bromoethanol (II), which is condensed with piperidine-4-carboxamide (III) by means of K2CO3 and KI in refluxing isopropanol, yielding the [14C]-labeled 1-(2-hydroxyethyl)piperidine-4-carboxamide (IV). The reaction of (IV) with SOCl2 in refluxing acetonitrile affords the 1-(2-chloroethyl)piperidine-4-carbonitrile (V), which is cyclized by means of lithium diisopropylamide in THF, giving the quinuclidine (VI). The hydrolysis of (VI) with sulfuric acid gives [14C]-labeled quinuclidine-4-carboxamide (VII), which is finally condensed with the 3-chloromethylcephalosporin (VIII) by means of Na in acetone and a treatment with trifluoroacetic acid.
【1】
Woolley, G.T.; Sugiyama, I.; Yamauchi, H.; Mizuo, H.; Synthesis of 14C-labelled cefclidin (E1040). J Label Compd Radiopharm 1992, 31, 9, 663.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(I) |
45074 |
2-bromoacetic acid
|
|
C2H3BrO2 |
详情 |
详情
|
(II) |
10059 |
Ethylene bromohydrin; 2-Bromo-1-ethanol
|
540-51-2 |
C2H5BrO |
详情 | 详情
|
(II) |
45075 |
2-bromo-1-ethanol
|
|
C2H5BrO |
详情 |
详情
|
(III) |
11762 |
4-Piperidinecarboxamide; Isonipecotamide
|
39546-32-2 |
C6H12N2O |
详情 | 详情
|
(IV) |
11763 |
1-(2-Hydroxyethyl)-4-piperidinecarboxamide
|
|
C8H16N2O2 |
详情 |
详情
|
(IV) |
45076 |
1-(2-hydroxyethyl)-4-piperidinecarboxamide
|
|
C8H16N2O2 |
详情 |
详情
|
(V) |
11764 |
1-(2-Chloroethyl)-4-piperidinecarbonitrile
|
|
C8H13ClN2 |
详情 |
详情
|
(V) |
45077 |
1-(2-chloroethyl)-4-piperidinecarbonitrile
|
|
C8H13ClN2 |
详情 |
详情
|
(VI) |
11765 |
4-Quinuclidinecarbonitrile
|
|
C8H12N2 |
详情 |
详情
|
(VI) |
45078 |
4-quinuclidinecarbonitrile
|
|
C8H12N2 |
详情 |
详情
|
(VII) |
11766 |
4-Quinuclidinecarboxamide
|
|
C8H14N2O |
详情 |
详情
|
(VII) |
45079 |
4-quinuclidinecarboxamide
|
|
C8H14N2O |
详情 |
详情
|
(VIII) |
11767 |
4-methoxybenzyl (6R,7R)-7-[[2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(methoxyimino)acetyl]amino]-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C21H21ClN6O6S2 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(II) Treatment of 2-(trityloxy)ethanol (I) with bromoacetic acid (II) and n-BuLi in THF affords ethoxyacetic acid derivative (III), which is then converted into ethyl ester (IV) by means of EtOH and DCC in CH2Cl2 in the presence of 4-pyrrolidinopyridine. Reaction of (IV) with Grignard reagent, prepared from 2-bromo-3-methylthiophene (V) and Mg turnings in THF, provides compound (VI), which is then converted into the corresponding tosylate derivative (VII) by treatment with BuLi and p-toluenesulfonyl chloride (p-TsCl) in toluene. Reaction of (VII) with (R)-ethyl nipecotate (VIII) and K2CO3 yields ethyl ester (IX), which is finally hydrolyzed with aqueous NaOH in EtOH followed by treatment with diluted HCl.
【1】
Knutsen, L.J.S.; Andersen, K.E.; Lau, J.; et al.; Synthesis of novel GABA uptake inhibitors. 3. Diaryloximine and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents. J Med Chem 1999, 42, 18, 3447.
|
【2】
Knutsen, L.J.S.; Jorgensen, A.S.; Andersen, K.E.; Sonnewald, U. (Novo Nordisk A/S); Novel N-substd. azaheterocyclic carboxylic acids. EP 0374801; JP 1990223551; US 5071859; US 5214057 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
42978 |
2-(trityloxy)-1-ethanol
|
|
C21H20O2 |
详情 |
详情
|
(II) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(III) |
42979 |
2-[2-(trityloxy)ethoxy]acetic acid
|
|
C23H22O4 |
详情 |
详情
|
(IV) |
42980 |
ethyl 2-[2-(trityloxy)ethoxy]acetate
|
|
C25H26O4 |
详情 |
详情
|
(V) |
12443 |
2-Bromo-3-methylthiophene
|
14282-76-9 |
C5H5BrS |
详情 | 详情
|
(VI) |
42981 |
2-[[2,2-bis(3-methyl-2-thienyl)vinyl]oxy]-1-ethanol
|
|
C14H16O2S2 |
详情 |
详情
|
(VII) |
42982 |
2-[[2,2-bis(3-methyl-2-thienyl)vinyl]oxy]ethyl 4-methylbenzenesulfonate
|
|
C21H22O4S3 |
详情 |
详情
|
(VIII) |
12453 |
ethyl (3R)hexahydro-3-pyridinecarboxylate
|
|
C8H15NO2 |
详情 |
详情
|
(IX) |
42983 |
ethyl (3R)-1-(2-[[2,2-bis(3-methyl-2-thienyl)vinyl]oxy]ethyl)-3-piperidinecarboxylate
|
|
C22H29NO3S2 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(V) The condensation of pyridoxal 5-phosphate (I) with ethylenediamine (II) in methanol by means of NaOH gives the corresponding diimine (III), which is reduced with hydrogen over Pt/C in methanol/water yielding the expected diamine (IV). The reaction of (IV) with bromoacetic acid (V) by means of NaOH in methanol/water affords the N,N'-diacetic acid derivative (VI), which is finally treated with MnCl2 in water containing NaOH.
【1】
Rocklage, S.M.; Cacheris, W.P.; Quay, S.C.; Hahn, F.E.; Raymond, K.N.; Manganese(II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate). Synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement. Inorg Chem 1989, 28, 477-85. |
【2】
Graul, A.; Leeson, P.; Castaner, J.; Mangafodipir Trisodium. Drugs Fut 1997, 22, 9, 974.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14753 |
Pyridoxal 5'-phosphate; (4-formyl-5-hydroxy-6-methyl-3-pyridinyl)methyl dihydrogen phosphate
|
54-47-7 |
C8H10NO6P |
详情 | 详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
14759 |
[5-hydroxy-4-[([2-[((E)-[3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methylidene)amino]ethyl]imino)methyl]-6-methyl-3-pyridinyl]methyl dihydrogen phosphate
|
|
C18H24N4O10P2 |
详情 |
详情
|
(IV) |
14756 |
[5-hydroxy-4-[([2-[([3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methyl)amino]ethyl]amino)methyl]-6-methyl-3-pyridinyl]methyl dihydrogen phosphate
|
|
C18H28N4O10P2 |
详情 |
详情
|
(V) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(VI) |
14758 |
2-[[2-[(carboxymethyl)([3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methyl)amino]ethyl]([3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methyl)amino]acetic acid
|
|
C22H32N4O14P2 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(A) The macrocyclic tetraamine (I) was protected as the triaminomethane derivative (VIII) by treatment with either triethyl orthoformate (4) or with dimethylformamide dimethylacetal (5). Alkylation of (VIII) with bromoacetic acid gave rise to the N-formyl N',N'',N'''-tris(carboxymethyl) compound (IX). After basic hydrolysis of the formamide function of (IX), the resultant N-deprotected amine (X) was condensed with epoxide (II) to yield (XI). Further complexation with GdCl3 and ketal group hydrolysis led to the target compound
【1】
Murru, M.; Ripa, G.; Scala, A.; Viscardi, C.F.; Ausonio, M.; Scotti, C.; Cossuta, P. (Bracco SpA; Dibra SpA); A process for the preparation of macrocyclic chelants and the chelates thereof with paramagnetic metal ions. WO 9856775 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(I) |
14855 |
1,4,7,10-tetraazacyclododecane; Cyclen
|
294-90-6 |
C8H20N4 |
详情 | 详情
|
(II) |
60022 |
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane
|
|
C7H12O3 |
详情 |
详情
|
(VIII) |
60028 |
octahydro-5H-2a,4a,7,9a-tetraazacycloocta[cd]pentalene
|
|
C9H18N4 |
详情 |
详情
|
(IX) |
60029 |
2-[4-formyl-7,10-bis(2-hydroxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetic acid
|
|
C15H26N4O7 |
详情 |
详情
|
(X) |
60030 |
trisodium 2-[4,10-bis(2-oxido-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate
|
|
C14H23N4Na3O6 |
详情 |
详情
|
(XI) |
60031 |
trisodium 2-[4-[(5R,6S)-6-hydroxy-2,2-dimethyl-1,3-dioxepan-5-yl]-7,10-bis(2-oxido-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate
|
|
C21H35N4Na3O9 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(A) In a related method for obtaining the precursor (V), epoxide (II) was condensed with the tosyl-protected tetraamine (XIII) in an autoclave at 170 C to give (XIV). The N-tosyl groups of (XIV) were then removed by treatment with lithium metal in liquid ammonia, yielding intermediate (III), which was then subjected to alkylation with bromoacetic acid, followed by acid hydrolysis
【1】
Platzek, J.; Gries, H.; Weinmann, H.-J.; Schuhmann-Giampieri, G.; Press, W.-R. (Schering AG); 1,4,7,10-Tetraazacyclododecane-butyl-triols, process for their preparation, and pharmaceutical agents containing these cpds.. DE 4009119; EP 0448191; US 2002176823; US 6399043 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(II) |
30022 |
1-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-propen-1-ol
|
|
C15H20O3 |
详情 |
详情
|
(III) |
60023 |
(5S,6R)-2,2-dimethyl-6-(1,4,7,10-tetraazacyclododecan-1-yl)-1,3-dioxepan-5-ol
|
|
C15H32N4O3 |
详情 |
详情
|
(V) |
60025 |
2-[4-[(1R,2S)-2,3-dihydroxy-1-(hydroxymethyl)propyl]-7,10-bis(2-hydroxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetic acid
|
|
C18H34N4O9 |
详情 |
详情
|
(XIII) |
60032 |
1,4,7-tris[(4-methylphenyl)sulfonyl]-1,4,7,10-tetraazacyclododecane
|
|
C29H38N4O6S3 |
详情 |
详情
|
(XIV) |
60033 |
(5S,6R)-2,2-dimethyl-6-{4,7,10-tris[(4-methylphenyl)sulfonyl]-1,4,7,10-tetraazacyclododecan-1-yl}-1,3-dioxepan-5-ol
|
|
C36H50N4O9S3 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(A) A different synthesis started from the previously reported tetraaza cyclopentaacenaphthylene (XV). Treatment of (XV) with a solution of piperazine at pH 6 gave rise to the bicyclic lactam (XVI). Alkylation of (XVI) with bromoacetic acid, followed by basic lactam hydrolysis furnished the tris(carboxymethyl) derivative (X), which was processed as in Scheme 3.
【1】
Argese, M.; Ripa, G. (Bracco SpA; Dibra SpA); 1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles. EP 0998476; JP 2002511884; WO 9905145 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(X) |
60030 |
trisodium 2-[4,10-bis(2-oxido-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate
|
|
C14H23N4Na3O6 |
详情 |
详情
|
(XV) |
60034 |
1,4,7,10-tetraazatricyclo[8.2.2.2~4,7~]hexadecane
|
|
C12H24N4 |
详情 |
详情
|
(XVI) |
60035 |
1,4,7,10-tetraazabicyclo[8.2.2]tetradecan-11-one
|
|
C10H20N4O |
详情 |
详情
|
(XVII) |
60036 |
2-[7-(2-hydroxy-2-oxoethyl)-11-oxo-1,4,7,10-tetraazabicyclo[8.2.2]tetradec-4-yl]acetic acid
|
|
C14H24N4O5 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) A new synthesis for ziprasidone hydrochloride has been reported:
The condensation of 6-chloroindolin-2-one (I) with bromoacetic acid (II) by means of polyphosphoric acid (PPA) gives 5-(bromoacetyl)-6-chloroindolin-2-one (III), which is reduced with triethylsilane and trifluoroacetic acid to the corresponding 2-bromoethyl derivative (IV). Finally, this compound is condensed with 4-(3-benzisothiazolyl)piperazine (V) by means of Na2CO3 in DMF or isobutyl methyl ketone.
【1】
Howard, H.R.; Lowe, J.A. III, Seeger, T.F.; et al.; 3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents. J Med Chem 1996, 39, 1, 143.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(II) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(III) |
16283 |
5-(2-bromoacetyl)-6-chloro-1,3-dihydro-2H-indol-2-one
|
|
C10H7BrClNO2 |
详情 |
详情
|
(IV) |
16284 |
5-(2-bromoethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
|
|
C10H9BrClNO |
详情 |
详情
|
(V) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
The reaction of 3-bromopropanol (I) with thiourea in refluxing water gives 3-sulfanylpropanol (II), which is cyclized with 2-phenylacetaldehyde (III) by means of p-toluenesulfonic acid in refluxing toluene yielding 2-benzyl-1,3-oxathiane (IV). The reductive cleavage of (IV) with Ca in liquid ammonia affords 3-(2-phenylethoxy)propanethiol (V), which is condensed with bromoacetic acid by means of NaH in DMF providing 2-[3-(2-phenylethoxy)propylsulfanyl]acetic acid (VI). The oxidation of (VI) with potassium peroxymonosulfate (oxone) gives the corresponding sulfonylacetic acid (VII), which is condensed with benzothiazolone (VIII) by means of DCC, HOBT and triethylamine in DMF yielding the correponding amide (IX). Finally, this compound is reduced with borane/THF yielding the target compound.
【1】
Bonnert, R.V.; Brown, R.C.; Chapman, D.; Cheshire, D.R.; Dixon, J.; Ince, F.; Kinchin, E.C.; Lyons, A.J.; Davis, A.M.; Hallam, C.; Harper, S.T.; Unitt, J.F.; Dougall, I.G.; Jackson, D.M.; McKechnie, K.; Young, A.; Simpson, W.T.; Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues. J Med Chem 1998, 41, 25, 4915. |
【2】
Bonnert, R.V.; Brown, R.C.; Cage, P.A.; et al.; Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airways diseases. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.275. |
【3】
Bonnert, R.V.; Brown, R.C.; Chapman, D.; et al.; Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airways diseases. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.276. |
【4】
Bonnert, R.V.; Brown, R.C.; Cheshire, D.R.; Ince, F. (AstraZeneca AB); 7-(2-Aminoethyl)-benzothiazolones. EP 0649418; JP 1996503923; US 5648370; WO 9324473 .
|
【5】
Castañer, J.; Graul, A.; Viozan. Drugs Fut 2000, 25, 2, 165.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
|
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(I) |
12573 |
3-Bromo-1-propanol; 3-Bromopropanol
|
627-18-9 |
C3H7BrO |
详情 | 详情
|
(II) |
25939 |
3-sulfanyl-1-propanol
|
19721-22-3 |
C3H8OS |
详情 | 详情
|
(III) |
18456 |
2-phenylacetaldehyde
|
122-78-1 |
C8H8O |
详情 | 详情
|
(IV) |
25940 |
2-benzyl-1,3-oxathiane
|
|
C11H14OS |
详情 |
详情
|
(V) |
25941 |
3-(phenethyloxy)propylhydrosulfide; 3-(phenethyloxy)-1-propanethiol
|
|
C11H16OS |
详情 |
详情
|
(VI) |
25942 |
2-[[3-(phenethyloxy)propyl]sulfanyl]acetic acid
|
|
C13H18O3S |
详情 |
详情
|
(VII) |
25943 |
2-[[3-(phenethyloxy)propyl]sulfonyl]acetic acid
|
|
C13H18O5S |
详情 |
详情
|
(VIII) |
25944 |
7-(2-aminoethyl)-4-hydroxy-1,3-benzothiazol-2(3H)-one
|
|
C9H10N2O2S |
详情 |
详情
|
(IX) |
25945 |
N-[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]-2-[[3-(phenethyloxy)propyl]sulfonyl]acetamide
|
|
C22H26N2O6S2 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
The reaction of 3-bromopropanol (I) with thiourea in refluxing water gives 3-sulfanylpropanol (II), which is cyclized with 2-phenylacetaldehyde (III) by means of p-toluenesulfonic acid in refluxing toluene yielding 2-benzyl-1,3-oxathiane (IV). The reductive cleavage of (IV) with Ca in liquid ammonia affords 3-(2-phenylethoxy)propanethiol (V), which is condensed with bromoacetic acid by means of NaH in DMF providing 2-[3-(2-phenylethoxy)propylsulfanyl]acetic acid (VI). The oxidation of (VI) with potassium peroxymonosulfate (oxone) gives the corresponding sulfonylacetic acid (VII).The condensation of sulfonylacetic acid (VII) with dimethoxybenzothiazole derivative (X) by means of DCC, HOBT and triethylamine in DMF gives the corresponding amide (XI), which is reduced with borane/THF yielding intermediate (XII). Finally, this compound is demethylated with concentrated HBr or HCl.
【1】
Bonnert, R.V.; Brown, R.C.; Cage, P.A.; et al.; Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airways diseases. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.275. |
【2】
Bonnert, R.V.; Brown, R.C.; Chapman, D.; et al.; Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airways diseases. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.276. |
【3】
Bonnert, R.V.; Brown, R.C.; Chapman, D.; Cheshire, D.R.; Dixon, J.; Ince, F.; Kinchin, E.C.; Lyons, A.J.; Davis, A.M.; Hallam, C.; Harper, S.T.; Unitt, J.F.; Dougall, I.G.; Jackson, D.M.; McKechnie, K.; Young, A.; Simpson, W.T.; Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues. J Med Chem 1998, 41, 25, 4915. |
【4】
Bonnert, R.V.; Brown, R.C.; Cheshire, D.R.; Ince, F. (AstraZeneca AB); 7-(2-Aminoethyl)-benzothiazolones. EP 0649418; JP 1996503923; US 5648370; WO 9324473 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
|
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(I) |
12573 |
3-Bromo-1-propanol; 3-Bromopropanol
|
627-18-9 |
C3H7BrO |
详情 | 详情
|
(II) |
25939 |
3-sulfanyl-1-propanol
|
19721-22-3 |
C3H8OS |
详情 | 详情
|
(III) |
18456 |
2-phenylacetaldehyde
|
122-78-1 |
C8H8O |
详情 | 详情
|
(IV) |
25940 |
2-benzyl-1,3-oxathiane
|
|
C11H14OS |
详情 |
详情
|
(V) |
25941 |
3-(phenethyloxy)propylhydrosulfide; 3-(phenethyloxy)-1-propanethiol
|
|
C11H16OS |
详情 |
详情
|
(VI) |
25942 |
2-[[3-(phenethyloxy)propyl]sulfanyl]acetic acid
|
|
C13H18O3S |
详情 |
详情
|
(VII) |
25943 |
2-[[3-(phenethyloxy)propyl]sulfonyl]acetic acid
|
|
C13H18O5S |
详情 |
详情
|
(X) |
25946 |
2-(2,4-dimethoxy-1,3-benzothiazol-7-yl)ethylamine; 2-(2,4-dimethoxy-1,3-benzothiazol-7-yl)-1-ethanamine
|
|
C11H14N2O2S |
详情 |
详情
|
(XI) |
25947 |
N-[2-(2,4-dimethoxy-1,3-benzothiazol-7-yl)ethyl]-2-[[3-(phenethyloxy)propyl]sulfonyl]acetamide
|
|
C24H30N2O6S2 |
详情 |
详情
|
(XII) |
25948 |
N-[2-(2,4-dimethoxy-1,3-benzothiazol-7-yl)ethyl]-N-(2-[[3-(phenethyloxy)propyl]sulfonyl]ethyl)amine; 2-(2,4-dimethoxy-1,3-benzothiazol-7-yl)-N-(2-[[3-(phenethyloxy)propyl]sulfonyl]ethyl)-1-ethanamine
|
|
C24H32N2O5S2 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(II) Acylation of L-leucine benzyl ester (I) with bromoacetic acid (II) in the presence of DCC and DMAP gave bromoacetamide (III), which upon reaction with triphenyl phosphine was converted to phosphonium salt (IV). After treatment of (IV) with Et3N, the resulting ylide was condensed with N-Boc-L-leucine (V) to yield the acyl- phosphonate (VI). Acid deprotection of the N-Boc group of (VI) provided amine (VII), which was condensed with the depsipeptide (VIII) using EDC and HOBt yielding (IX). Removal of the N-Fmoc group from tetrapeptide (IX) was effected by treatment with piperidine in DMF, and the resulting amino compound was further condensed with protected L-asparagine (X) to furnish peptide (XI). After hydrogenolytic removal of the benzyl and carbobenzoxy groups of (XI), treatment with diphenyl phosphoryl azide and NaHCO3 produced the cyclic depsipeptide (XII).
【1】
Wasserman, H.H.; et al.; The chemistry of vicinal tricarbonyls: Total syntheses of elastase inhibitors YM-47141 and YM-47142. Helv Chim Acta 2000, 83, 9, 2607.
|
【2】
Wasserman, H.H.; et al.; Total syntheses of depsipeptide elastase inhibitor. J Am Chem Soc 1999, 121, 6, 1401.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22252 |
Benzyl (2S)-2-amino-4-methylpentanoate; Benzyl (S)-leucinate
|
|
C13H19NO2 |
详情 |
详情
|
(II) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(III) |
23661 |
benzyl (2S)-2-[(2-bromoacetyl)amino]-4-methylpentanoate
|
|
C15H20BrNO3 |
详情 |
详情
|
(IV) |
23662 |
benzyl (2S)-4-methyl-2-[[2-(triphenylphosphoranyl)acetyl]amino]pentanoate
|
|
C33H36NO3P |
详情 |
详情
|
(V) |
23663 |
(2S)-2-[(tert-butoxycarbonyl)amino]-4-methylpentanoic acid;N-Boc-L-leucine |
|
C11H21NO4 |
详情 |
详情
|
(VI) |
23664 |
benzyl (2S)-2-[[(4S)-4-[(tert-butoxycarbonyl)amino]-6-methyl-3-oxo-2-(triphenylphosphoranylidene)heptanoyl]amino]-4-methylpentanoate
|
|
C44H53N2O6P |
详情 |
详情
|
(VII) |
23665 |
benzyl (2S)-2-[[(4S)-4-amino-6-methyl-3-oxo-2-(triphenylphosphoranylidene)heptanoyl]amino]-4-methylpentanoate
|
|
C39H45N2O4P |
详情 |
详情
|
(VIII) |
23666 |
(2S,3S)-2-[(tert-butoxycarbonyl)amino]-3-[((2R)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]propanoyl)oxy]butyric acid
|
|
C27H32N2O8 |
详情 |
详情
|
(IX) |
23667 |
benzyl (5R,8S,9S,12S,17S)-9-[(tert-butoxycarbonyl)amino]-1-(9H-fluoren-9-yl)-12,17-diisobutyl-5,8-dimethyl-3,6,10,13,15-pentaoxo-14-(triphenylphosphoranylidene)-2,7-dioxa-4,11,16-triazaoctadecan-18-oate
|
|
C66H75N4O11P |
详情 |
详情
|
(X) |
23668 |
|
|
C13H16N2O5 |
详情 |
详情
|
(XI) |
23669 |
|
|
C64H79N6O13P |
详情 |
详情
|
(XII) |
23670 |
|
|
C49H65N6O10P |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(II) Acylation of L-leucine benzyl ester (I) with bromoacetic acid (II) in the presence of DCC and DMAP gave bromoacetamide (III), which upon reaction with triphenyl phosphine was converted to phosphonium salt (IV). After treatment of (IV) with Et3N, the resulting ylide was condensed with N-Boc-L-leucine (V) to yield the acyl- phosphonate (VI). Acid deprotection of the N-Boc group of (VI) provided amine (VII), which was condensed with the depsipeptide (VIII) using EDC and HOBt yielding (IX). Removal of the N-Fmoc group from tetrapeptide (IX) was effected by treatment with piperidine in DMF, and the resulting amino compound was further condensed with protected L-asparagine (X) to furnish peptide (XI). After hydrogenolytic removal of the benzyl and carbobenzoxy groups of (XI), treatment with diphenyl phosphoryl azide and NaHCO3 produced the cyclic depsipeptide (XII).
【1】
Wasserman, H.H.; et al.; The chemistry of vicinal tricarbonyls: Total syntheses of elastase inhibitors YM-47141 and YM-47142. Helv Chim Acta 2000, 83, 9, 2607.
|
【2】
Wasserman, H.H.; et al.; Total syntheses of depsipeptide elastase inhibitor. J Am Chem Soc 1999, 121, 6, 1401.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22252 |
Benzyl (2S)-2-amino-4-methylpentanoate; Benzyl (S)-leucinate
|
|
C13H19NO2 |
详情 |
详情
|
(II) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(III) |
23661 |
benzyl (2S)-2-[(2-bromoacetyl)amino]-4-methylpentanoate
|
|
C15H20BrNO3 |
详情 |
详情
|
(IV) |
23662 |
benzyl (2S)-4-methyl-2-[[2-(triphenylphosphoranyl)acetyl]amino]pentanoate
|
|
C33H36NO3P |
详情 |
详情
|
(V) |
23663 |
(2S)-2-[(tert-butoxycarbonyl)amino]-4-methylpentanoic acid;N-Boc-L-leucine |
|
C11H21NO4 |
详情 |
详情
|
(VI) |
23664 |
benzyl (2S)-2-[[(4S)-4-[(tert-butoxycarbonyl)amino]-6-methyl-3-oxo-2-(triphenylphosphoranylidene)heptanoyl]amino]-4-methylpentanoate
|
|
C44H53N2O6P |
详情 |
详情
|
(VII) |
23665 |
benzyl (2S)-2-[[(4S)-4-amino-6-methyl-3-oxo-2-(triphenylphosphoranylidene)heptanoyl]amino]-4-methylpentanoate
|
|
C39H45N2O4P |
详情 |
详情
|
(VIII) |
23666 |
(2S,3S)-2-[(tert-butoxycarbonyl)amino]-3-[((2R)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]propanoyl)oxy]butyric acid
|
|
C27H32N2O8 |
详情 |
详情
|
(IX) |
23667 |
benzyl (5R,8S,9S,12S,17S)-9-[(tert-butoxycarbonyl)amino]-1-(9H-fluoren-9-yl)-12,17-diisobutyl-5,8-dimethyl-3,6,10,13,15-pentaoxo-14-(triphenylphosphoranylidene)-2,7-dioxa-4,11,16-triazaoctadecan-18-oate
|
|
C66H75N4O11P |
详情 |
详情
|
(X) |
23668 |
|
|
C13H16N2O5 |
详情 |
详情
|
(XI) |
23669 |
|
|
C64H79N6O13P |
详情 |
详情
|
(XII) |
23670 |
|
|
C49H65N6O10P |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(XIII) Further coupling and deprotection cycles incorporating peptoid N-Fmoc-N-benzylglycine (X), and twice peptoid (VIII), yielded the peptoid-resins (XI) and (XII), respectively. Bromoacetic acid (XIII) was subsequently coupled to resin (XII) to afford the bromoacetamido peptoid-resin (XIV).
【1】
Hamy, F.; et al.; An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication. Proceedings of the National Academy of Sciences of the United States of America 1997, 94, 8, 3548.
|
【2】
Felder, E.; Hamy, F.; Heizmann, G.; Klimkait, T.; Lazdins, J.K. (Novartis AG); Antiviral peptoid cpds.. EP 0832110; WO 9640759 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
42845 |
2-([(9H-fluoren-9-ylmethoxy)carbonyl][3-[(imino[[(2,2,5,7,8-pentamethyl-3,4,4a,8a-tetrahydro-2H-chromen-6-yl)sulfonyl]amino]methyl)amino]propyl]amino)acetic acid
|
|
C35H44N4O7S |
详情 |
详情
|
(IX) |
42846 |
tert-butyl (5R,8R)-5-[([(1R)-1-[[(2R)-2-(aminocarbonyl)pyrrolidinyl]carbonyl]-4-[(imino[[(2,2,5,7,8-pentamethyl-3,4,4a,8a-tetrahydro-2H-chromen-6-yl)sulfonyl]amino]methyl)amino]butyl]amino)carbonyl]-8-[4-[(tert-butoxycarbonyl)amino]butyl]-17-imino-7
|
|
C67H114N14O15S2 |
详情 |
详情
|
(X) |
42848 |
2-[benzyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]acetic acid
|
|
C24H21NO4 |
详情 |
详情
|
(XI) |
42849 |
tert-butyl (5R,8R)-5-[([(1R)-1-[[(2R)-2-(aminocarbonyl)pyrrolidinyl]carbonyl]-4-[(imino[[(2,2,5,7,8-pentamethyl-3,4,4a,8a-tetrahydro-2H-chromen-6-yl)sulfonyl]amino]methyl)amino]butyl]amino)carbonyl]-12-[2-(benzylamino)acetyl]-8-[4-[(tert-butoxycarbo
|
|
C76H123N15O16S2 |
详情 |
详情
|
(XII) |
42850 |
|
|
C116H187N23O24S4 |
详情 |
详情
|
(XIII) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(XIV) |
42851 |
|
|
C118H188BrN23O25S4 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(VI) The deprotection of the resin (I) with piperidine in DMF gives the amino-resin (II), which is condensed with N-Fmoc-L-proline (III) by means of diisopropylcarbodiimide (DIC) in DMF to yield the anchored proline (IV). The deprotection of (IV) with piperidine in DMF affords compound (V) with a free NH group, which is condensed with 2-bromoacetic acid (VI) by means of DIC DMF to provide the bromoacetyl proline resin (VII). The condensation of (VII) with 6-(2-aminoethylamino)pyridine-3-carbonitrile (VIII) in DMSO to give the resin anchored precursor (IX), which is finally cleaved by means of trifluoroacetic anhydride (TFAA) in THF to furnish the target pyrrolidine-carbonitrile.
Alternatively, the acylation of L-prolinamide (X) with 2-bromoacetyl bromide (XI) by means of TEA and DMAP in dichloromethane gives the 1-(2-bromoacetyl)-L-prolinamide (XII), which is dehydrated by means of TFAA in dichloromethane to yield the pyrrolidine-carbonitrile (XIII). Finally, this compound is condensed with 6-(2-aminoethylamino)pyridine-3-carbonitrile (VIII) in THF to furnish the target pyrrolidine-carbonitrile.
【1】
Mangold, B.L.; Mone, M.D.; Dunning, B.E.; Russell, M.E.; Brinkman, J.A.; Weldon, S.C.; Hughes, T.E.; Naderi, G.B.; Villhauer, E.B.; 1-[2-[(5-Cyanopyridin-2-yl)amino]-ethylamino]acetyl-2-(S)-pyrrolidine-carbonitrile: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. J Med Chem 2002, 45, 12, 2362. |
【2】
Villhauer, E.B. (Novartis AG); N-Substd. 2-cyanopyrrolidines. JP 2000511559; WO 9819998 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V),(X) |
36137 |
(2S)-2-pyrrolidinecarboxamide;L-prolinamide |
7531-52-4 |
C5H10N2O |
详情 | 详情
|
(VII),(XII) |
54331 |
(2S)-1-(2-bromoacetyl)-2-pyrrolidinecarboxamide
|
n/a |
C7H11BrN2O2 |
详情 | 详情
|
(I) |
28722 |
9H-fluoren-9-ylmethyl carbamate
|
84418-43-9 |
C15H13NO2 |
详情 | 详情
|
(III) |
34762 |
(2S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-pyrrolidinecarboxylic acid
|
71989-31-6 |
C20H19NO4 |
详情 | 详情
|
(IV) |
42841 |
9H-fluoren-9-ylmethyl (2R)-2-(aminocarbonyl)-1-pyrrolidinecarboxylate
|
|
C20H20N2O3 |
详情 |
详情
|
(VI) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(VIII) |
54332 |
6-[(2-aminoethyl)amino]nicotinonitrile
|
n/a |
C8H10N4 |
详情 | 详情
|
(IX) |
54333 |
(2S)-1-[2-({2-[(5-cyano-2-pyridinyl)amino]ethyl}amino)acetyl]-2-pyrrolidinecarboxamide
|
n/a |
C15H20N6O2 |
详情 | 详情
|
(XI) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(XIII) |
54334 |
(2S)-1-(2-bromoacetyl)-2-pyrrolidinecarbonitrile
|
n/a |
C7H9BrN2O |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(V) The condensation of protected L-proline (I) with RINK RESIN (II) by means of TBTU, HOBT and DIEA in DMF gives the protected, rein bounded proline (III), which is deprotected by means of piperidine in DMF to yield the resin bounded proline (IV). The condensation of (IV) with 2-bromoacetic acid (V) by means of DIC in the same solvent affords the acyl proline (VI), which is treated with ethylene-1,2-diamine (VII) to provide the aminoacetyl proline (VIII). The condensation of (VIII) with 2-acetyldimedone (IX) gives the regioselectively monoprotected diaminoproline compound (X), which is treated with Boc2O and DIEA in dioxane to protect the secondary amino group of (X) and yield (XI). The selective elimination of the dimedone protecting group with hydrazine in DMF affords compound (XII) selectively monoprotected at the secondary amino group, which is condensed with 6-chloropyridine-3-carbonitrile (XIII) by means of DIEA in NMP to provide the resin adduct (XIV). The cleavage of the resin group of (XIV) by means of TFA and TFAA in dichloromethane takes place with simultaneous dehydration of the carboxamide group and removal of the Boc protecting group affording the trifluoroacetamido derivative (XV). Finally, the trifluoroacetyl group is removed by means of NH3 in aqueous methanol to give rise to the target pyridine carbonitrile derivative.
【1】
Willand, N.; et al.; Solid and solution phase syntheses of the 2-cyanopyrrolidide DPP-IV inhihitor NVP-DPP728. Tetrahedron 2002, 58, 28, 5741.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34762 |
(2S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-pyrrolidinecarboxylic acid
|
71989-31-6 |
C20H19NO4 |
详情 | 详情
|
(III) |
42841 |
9H-fluoren-9-ylmethyl (2R)-2-(aminocarbonyl)-1-pyrrolidinecarboxylate
|
|
C20H20N2O3 |
详情 |
详情
|
(IV) |
36137 |
(2S)-2-pyrrolidinecarboxamide;L-prolinamide |
7531-52-4 |
C5H10N2O |
详情 | 详情
|
(V) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(VI) |
54331 |
(2S)-1-(2-bromoacetyl)-2-pyrrolidinecarboxamide
|
n/a |
C7H11BrN2O2 |
详情 | 详情
|
(VII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(VIII) |
57168 |
(2S)-1-{2-[(2-aminoethyl)amino]acetyl}-2-pyrrolidinecarboxamide
|
|
C9H18N4O2 |
详情 |
详情
|
(IX) |
57169 |
2-(1-hydroxyethylidene)-5,5-dimethyl-1,3-cyclohexanedione
|
|
C10H14O3 |
详情 |
详情
|
(X) |
57170 |
(2S)-1-{2-[(2-{[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino}ethyl)amino]acetyl}-2-pyrrolidinecarboxamide
|
|
C19H30N4O4 |
详情 |
详情
|
(XI) |
57171 |
tert-butyl 2-[(2S)-2-(aminocarbonyl)pyrrolidinyl]-2-oxoethyl(2-{[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino}ethyl)carbamate
|
|
C24H38N4O6 |
详情 |
详情
|
(XII) |
57172 |
tert-butyl 2-[(2S)-2-(aminocarbonyl)pyrrolidinyl]-2-oxoethyl(2-aminoethyl)carbamate
|
|
C14H26N4O4 |
详情 |
详情
|
(XIII) |
57164 |
2-Chloro-5-cyanopyridine; 6-Chloro-3-cyanopyridine; 6-Chloronicotinonitrile
|
33252-28-7 |
C6H3ClN2 |
详情 | 详情
|
(XIV) |
57173 |
tert-butyl 2-[(2S)-2-(aminocarbonyl)pyrrolidinyl]-2-oxoethyl{2-[(5-cyano-2-pyridinyl)amino]ethyl}carbamate
|
|
C20H28N6O4 |
详情 |
详情
|
(XV) |
57174 |
N-{2-[(5-cyano-2-pyridinyl)amino]ethyl}-N-{2-[(2S)-2-cyanopyrrolidinyl]-2-oxoethyl}-2,2,2-trifluoroacetamide
|
|
C17H17F3N6O2 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(IV) Ring opening of cyclohexene oxide (I) with phenylmagnesium bromide in the presence of CuI, followed by acetylation of the resulting alcohol (II) gave the racemic trans-2-phenylcyclohexyl acetate (III). Enzymatic resolution of (III) using porcine liver acetone powder yielded the desired (-)-alcohol (II) along with unreacted (+)-acetate (III). Condensation of the sodium alkoxide of benzyl alcohol with bromoacetic acid (IV) afforded benzyloxyacetic acid (V), which was then coupled with the chiral alcohol (-)-(II) to give ester (VI). Hydrogenolysis of the O-benzyl group of (VI), followed by silylation of the resulting hydroxyacetate ester (VII) with triisopropylsilyl chloride, furnished (VIII). Imine (XI) was prepared by condensation of 3-methyl-2-butenal (IX) with p-anisidine (X). The asymmetric cyclocondensation reaction of the lithium enolate derived from ester (VIII) with imine (XI) yielded the chiral beta-lactam (XII). Oxidative removal of the p-methoxyphenyl protecting group of (XII) and then reprotection of the lactam N atom with Boc2O furnished the intermediate N-Boc lactam (XIII).
【1】
Strum, M.; Tynebor, R.; Pera, P.; Bernacki, R.J.; Ojima, I.; Synthesis and SAR of advanced second generation taxoids. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 132.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(rac)-(III) |
51206 |
(1R,2S)-2-phenylcyclohexyl acetate
|
|
C14H18O2 |
详情 |
详情
|
(rac)-(II) |
51208 |
(1R,2S)-2-phenylcyclohexanol
|
|
C12H16O |
详情 |
详情
|
(-)-(II) |
51209 |
(-)-(1R,2S)-2-phenylcyclohexanol
|
|
C12H16O |
详情 |
详情
|
(+)-(III) |
51210 |
(1S,2R)-2-phenylcyclohexyl acetate
|
|
C14H18O2 |
详情 |
详情
|
(I) |
17986 |
7-oxabicyclo[4.1.0]heptane; cyclohexene oxide
|
286-20-4 |
C6H10O |
详情 | 详情
|
(IV) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(V) |
51207 |
2-(benzyloxy)acetic acid
|
|
C9H10O3 |
详情 |
详情
|
(VI) |
51211 |
(1R,2S)-2-phenylcyclohexyl 2-(benzyloxy)acetate
|
|
C21H24O3 |
详情 |
详情
|
(VII) |
51212 |
(1R,2S)-2-phenylcyclohexyl 2-hydroxyacetate
|
|
C14H18O3 |
详情 |
详情
|
(VIII) |
19151 |
(1R,2S)-2-phenylcyclohexyl 2-[(triisopropylsilyl)oxy]acetate
|
|
C23H38O3Si |
详情 |
详情
|
(IX) |
19152 |
3-methyl-2-butenal
|
107-86-8 |
C5H8O |
详情 | 详情
|
(X) |
10478 |
p-Anisidine; 4-Methoxyaniline; 4-Methoxyphenylamine
|
104-94-9 |
C7H9NO |
详情 | 详情
|
(XI) |
19154 |
4-methoxy-N-[(E)-3-methyl-2-butenylidene]aniline; N-(4-methoxyphenyl)-N-[(E)-3-methyl-2-butenylidene]amine
|
|
C12H15NO |
详情 |
详情
|
(XII) |
19155 |
(3R,4S)-1-(4-methoxyphenyl)-4-(2-methyl-1-propenyl)-3-[(triisopropylsilyl)oxy]-2-azetidinone
|
|
C23H37NO3Si |
详情 |
详情
|
(XIII) |
19157 |
tert-butyl (2S,3R)-2-(2-methyl-1-propenyl)-4-oxo-3-[(triisopropylsilyl)oxy]-1-azetidinecarboxylate
|
|
C21H39NO4Si |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(III) The hydrolysis of the known thioacetate (I) with NaOH in THF gives the thiol (II), which is condensed with 14C-labelled bromoacetic acid (III) by means of NaOH in water to yield the sulfanyl-acetic acid (IV). The reduction of (IV) with LiAlH4 in THF affords the sulfanylethanol derivative (V); which is condensed with 3-(4-hydroxyphenyl)propionic acid methyl ester (VI) by means of DEAD and PPh3 in toluene to provide the labelled aryl ether (VII).The hydrolysis of the ester group of (VII) by means of KOH in ethanol/water gives the propionic acid (VIII), which is converted into the trifluoromethyl ketone (IX) by reaction with oxalyl chloride, trifluoroacetic anhydride and pyridine in toluene/dichloromethane. Finally, the oxidation of the sulfanyl group of (IX) with MCPBA in dichloromethane affords the target labelled sulfone.
【1】
Dischino, D.D.; Banville, J.; Remillard, R.; Synthesis of carbon-14 labeled 4-[4-[2-[2-[bis(4-chlorophenyl)methoxy]ethylsulfonyl][1-14C]ethoxy]phenyl]-1,1,1-trifluoro-2-butanone. J Label Compd Radiopharm 2003, 46, 2, 167.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
64511 |
S-{2-[bis(4-chlorophenyl)methoxy]ethyl} ethanethioate
|
|
C17H16Cl2O2S |
详情 |
详情
|
(II) |
64512 |
2-[bis(4-chlorophenyl)methoxy]ethylhydrosulfide; 2-[bis(4-chlorophenyl)methoxy]-1-ethanethiol
|
|
C15H14Cl2OS |
详情 |
详情
|
(III) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(III) |
64514 |
2-bromoacetic acid
|
|
C2H3BrO2 |
详情 |
详情
|
(IV) |
64513 |
2-({2-[bis(4-chlorophenyl)methoxy]ethyl}sulfanyl)acetic acid
|
|
C17H16Cl2O3S |
详情 |
详情
|
(IV) |
64515 |
2-({2-[bis(4-chlorophenyl)methoxy]ethyl}sulfanyl)acetic acid
|
|
C17H16Cl2O3S |
详情 |
详情
|
(V) |
50507 |
2-([2-[bis(4-chlorophenyl)methoxy]ethyl]sulfanyl)-1-ethanol
|
|
C17H18Cl2O2S |
详情 |
详情
|
(V) |
64516 |
2-({2-[bis(4-chlorophenyl)methoxy]ethyl}sulfanyl)-1-ethanol
|
|
C17H18Cl2O2S |
详情 |
详情
|
(VI) |
30341 |
methyl 3-(4-hydroxyphenyl)propanoate; 4-Hydroxyphenylpropionic acid methyl ester; 3-(4-Hydroxyphenyl)propionic acid methyl ester
|
5597-50-2 |
C10H12O3 |
详情 | 详情
|
(VII) |
50508 |
methyl 3-[4-[2-([2-[bis(4-chlorophenyl)methoxy]ethyl]sulfanyl)ethoxy]phenyl]propanoate
|
|
C27H28Cl2O4S |
详情 |
详情
|
(VII) |
64517 |
methyl 3-{4-[2-({2-[bis(4-chlorophenyl)methoxy]ethyl}sulfanyl)ethoxy]phenyl}propanoate
|
|
C27H28Cl2O4S |
详情 |
详情
|
(VIII) |
50509 |
3-[4-[2-([2-[bis(4-chlorophenyl)methoxy]ethyl]sulfanyl)ethoxy]phenyl]propionic acid
|
|
C26H26Cl2O4S |
详情 |
详情
|
(VIII) |
64518 |
3-{4-[2-({2-[bis(4-chlorophenyl)methoxy]ethyl}sulfanyl)ethoxy]phenyl}propanoic acid
|
|
C26H26Cl2O4S |
详情 |
详情
|
(IX) |
50510 |
4-[4-[2-([2-[bis(4-chlorophenyl)methoxy]ethyl]sulfanyl)ethoxy]phenyl]-1,1,1-trifluoro-2-butanone
|
|
C27H25Cl2F3O3S |
详情 |
详情
|
(IX) |
64519 |
4-{4-[2-({2-[bis(4-chlorophenyl)methoxy]ethyl}sulfanyl)ethoxy]phenyl}-1,1,1-trifluoro-2-butanone
|
|
C27H25Cl2F3O3S |
详情 |
详情
|